Close

Articles Posted in Product Liability

Updated:

Federal DePuy ASR Trial Set For September

A New York woman, Ann McCracken’s defective hip claim will be the first DePuy ASR hip lawsuit to go to trial in federal court.  McCracken’s case is a “bellwether” case, designed to determine how juries will respond to presented evidence and testimony. 7,800 Federal DePuy ASR Lawsuits More than 7,800…

Updated:

Concerns About Byetta, Januvia and Victoza Drug Safety

The National Institutes of Health held a workshop, addressing the risks associated with the newer diabetic drugs. These medications, known as Incretic Mimetics are coming under fire for alleged increased risk of pancreatic cancer. Merck & Co., Novo Nordisk A/S and others, the manufacturers of these drugs may be asked…

Updated:

Stryker Rejuvenate and ABG II Hip Lawsuits MDL

Earlier this year, motions for federal centralization of pretrial proceedings in the Stryker Rejuvenate and ABG II modular-neck hip implant products lawsuits were presented for consideration by the United States Judicial Panel on Multidistrict Litigation, JPML. The injury cases in this litigation involve alleged defects in Stryker’s Rejuvenate and ABG…

Updated:

Vaginal Mesh Prolapse Lawsuits Making Progress

Two years ago the FDA announced that there was no evidence that transvaginal mesh provides any benefits when compared to traditional surgery. Unfortunately according to medical studies, transvaginal mesh procedure and device implantation has a risk of serious complications. The FDA issued warnings about the safety of surgical mesh for…

Updated:

Byetta Thyroid Cancer Claim Against Amylin & Eli Lilly

As a Byetta/Januvia/Victoza Thyroid and Pancreatic Cancer attorney and a Texas medical doctor, I am providing this litigation update regarding Incretic Mimetics lawsuits. A 23 year old woman has filed a product liability lawsuit against Amylin Pharmaceuticals and Eli Lilly & Co., claiming that she developed thyroid cancer from side…

Contact Us
Start Chat